IDF general


UN Summit on NCDs

National Diabetes Programmes

Diabetes and oral health - information for health professionals

Diabetes and oral health - information for the public

Sleep apnoea and type 2 diabetes

Recent research demonstrates the likelihood of a relationship between type 2 diabetes and obstructive sleep apnoea (OSA), the most common form of sleep disordered breathing. The IDF consensus statement on sleep apnoea and type 2 diabetes wants to raise awareness of the association between the two conditions, which have significant implications on public health and on the lives of individuals.
A few facts:

IDF Reference Centres for Diabetes Education




IDF Centres of Education (IDFCE) programme was launched in 2009. IDF has now renamed the 'IDFCE' to 'IDF Reference Centers for Diabetes Education' - (IDF-RCDE), and revised the criteria, terms and conditions.

Diabetes and oral health

The World Dental Federation (FDI) and the International Diabetes Federation (IDF) jointly organised a symposium on Oral Health and Diabetes* on 25 October 2007 during the FDI Annual World Dental Congress in Dubai, UAE.  The presenting experts and all participants welcomed the initiative of the two convening organisations to emphasize the interrelationship between diabetes and oral health.

Guideline for Management of Postmeal Glucose 2007

Criteria of metabolic syndrome in children and adolescents

Age 6 to <10 years

  • Obesity > 90th percentile as assessed by waist circumference
  • Metabolic syndrome cannot be diagnosed, but further measurements should be made if family history of metabolic syndrome, type 2 diabetes mellitus, dyslipidaemia, cardiovascular disease, hypertension, or obesity
  • IDF suggests that a strong message for weight reduction should be delivered for those with abdominal obesity

Age 10 to <16 years

IDF definition of metabolic syndrome in children and adolescents

The International Diabetes Federation (IDF) has launched a new definition to identify children and adolescents at increased risk of developing type 2 diabetes and cardiovascular disease in later life. The definition has been published in The Lancet¹ and is also available as a booklet.